资产 更改
Akebia Therapeutics USD 362.52M 14.04M 2026-03
Alaunos Therapeutics USD 1.88M 1.08M 2026-03
Avita Medical AUD 56.39M 1.74M 2025-12
Clinuvel Pharmaceuticals AUD 269.7M 2.05M 2025-12
Dianthus Therapeutics USD 1.25B 715.96M 2026-03
Genetic Signatures AUD 49.04M 5.59M 2025-12
Ionis Pharmaceuticals USD 3.45B 74M 2026-03
Medical Developments International AUD 63.57M 2.83M 2025-12
Neuren Pharmaceuticals AUD 342.86M 11.61M 2025-12
Organon & Co USD 13B 129M 2026-03
Paradigm Biopharmaceuticals AUD 23.15M 1.42M 2025-12
PYC Therapeutics AUD 159.13M 24.15M 2025-12
Starpharma Holdings AUD 26.17M 746K 2025-12
Tectonic Therapeutic USD 246.58M 14.46M 2026-03
Telix Pharmaceuticals AUD 1.16B 25.97M 2025-12
Viatris USD 36.83B 358.5M 2026-03
Xeris Pharmaceuticals USD 392.01M 8.49M 2026-03